![]() |
|
|
Division of Nutrition, University of Helsinki, Helsinki, Finland
3To whom correspondence should be addressed. E-mail: marjo.misikangas{at}helsinki.fi.
| ABSTRACT |
|---|
|
|
|---|
-tocopherol.
No differences between groups were seen in indices of platelet
activation, including platelet aggregation, total PKC activity and
distribution of PKC isoenzymes
, ßII and
. The
results indicate that in apparently healthy and fairly young subjects
with adequate vitamin intakes, diets differing markedly in their
amounts of linoleic and oleic acids, and vegetables, berries and apples
do not differ in platelet activation.
KEY WORDS: vegetables unsaturated fatty acids protein kinase C platelet activation humans
| INTRODUCTION |
|---|
|
|
|---|
Platelets have an important role in atherosclerosis and thrombosis
(1)
, and platelet hyperactivity is considered to be a risk
factor for thrombosis (2)
. Oxygen free radicals modulate
platelet activation, and thus oxidative stress may lead to unfavorable
platelet activation. There is substantial evidence that diet may affect
platelets, and dietary fatty acids, in particular, have been widely
studied (3)
. Dietary studies have focused mainly on
platelet aggregation ex vivo, even though diet can affect the earlier
steps of platelet activation, and signaling molecules upstream in the
pathway may serve as a marker of activation. The cell-signaling
molecules of platelet activation cascades, e.g., protein kinase C
(PKC), have been studied in vitro, but their usefulness as a platelet
activation marker in dietary studies is unknown.
PKC is an important enzyme in cell-signaling pathways. Activation
of PKC is necessary to the platelet activation process, leading to
platelet secretion and aggregation (4
,5)
. Upregulation of
platelet PKC could be one step resulting in platelet hyperactivity. The
translocation of the enzyme from cell cytosol to plasma membrane is
considered to be a critical point in the classical PKC activation model
(6)
.
Cis-unsaturated fatty acids directly activate PKC in vitro
(7)
, and some evidence indicates that platelet PKC
activity may be modulated by dietary fatty acids also in vivo
(8)
. Oleic acid (9)
and (n-6) and (n-3) PUFA
(10)
can induce PKC translocation to the plasma membrane
in vitro. Oxygen free radicals (11)
and oxidation products
of unsaturated fatty acids (12)
stimulate PKC activity in
vitro, which could be mediated at least in part by the phosphorylation
of PKC
(13)
.
Some antioxidants and other bioactive molecules from plant sources
inhibit PKC activity in vitro. Vitamin E can reduce platelet
aggregation through a PKC-dependent mechanism (14)
.
This action is independent of the antioxidant activity of
-tocopherol (15)
and seems to be mediated by the
ability of
-tocopherol to dephosphorylate PKC
(16)
.
-Tocopherol also inhibits redistribution of PKC activity from the
cytosol to the membrane compartment (17)
. Flavonoids
naturally present in plants can inhibit PKC in vitro (18)
;
however, information about other possible bioactive compounds in
vegetables, fruits and berries is insufficient.
As part of a larger intervention examining the effects of diets
differing markedly in their amounts of linoleic or oleic acids, and
vegetables, berries and apples, we report here the effects of the two
extremes of the experimental diets on platelet activation. The diets
studied were a high linoleic acid/low vegetable diet [LA(-)] and a
high oleic acid/high vegetable diet [OA(+)]. In addition to platelet
aggregation ex vivo, total PKC activity and distribution of PKC
isoenzymes were followed as earlier markers of platelet activation. The
three isoenzymes chosen,
, ßII and
, are
modulated by dietary constituents in vitro (9
,13
,16)
.
| SUBJECTS AND METHODS |
|---|
|
|
|---|
|
|
For PKC analysis, platelets were equilibrated for 3060 min at 25°C.
Equal volumes of ice-cold washing buffer [acid-citrate-dextrose
/saline] (19)
were added to platelet-rich
plasma and platelets were pelleted by centrifugation at 700 x g for 10 min at 4°C. For the separation of platelet
cytosolic and membrane fractions, the platelet pellet was resuspended
in 5 mL ice-cold homogenization buffer containing 20 mmol/L
Tris-HCl (pH 7.4), 10 mmol/L EGTA, 2 mL EDTA, 250 mmol/L sucrose, 1
mmol/L phenylmethylsulfonyl fluoride and 0.5 mg leupeptin. The
suspension was sonicated (Labsonic 2000V, B. Braun,Markheidenfelt,Germany) in an ice bath for 30 s. The homogenate
was centrifuged at 100,000 x g for 1 h at 4°C
(Beckman L870M, Palo Alto, CA). The supernatant was collected and
used as the PKC cytosolic fraction. The pellet was resuspended in 5 mL
of ice-cold homogenization buffer containing 2 mL/L Triton X-100,
incubated for 20 min and centrifuged at 100,000 x g
for 1 h at 4°C. The resulting supernatant was used as the
platelet membrane fraction.
Total PKC activity was measured from the cytosolic and membrane fractions. Membrane fractions were partially purified with DEAE-Sephacel chromatography (Pharmacia, Uppsala, Sweden) and stored at -70°C, whereas cytosolic fractions were stored unpurified. PKC activities in both fractions were analyzed by Biotrak RPN 77 assay (Amersham, Little Chalfont, UK) and standardized by protein concentrations, which were measured using a BioRad protein assay reagent (Hercules, CA) with bovine serum albumin as the standard.
For the analysis of PKC isoenzymes, cytosol and membrane fractions were
stored at -70°C until concentrated using Ultrafree-4 concentrators
(Millipore, Bedford, MA). Protein contents were measured using the
BioRad protein assay reagent with bovine serum albumin as the standard.
The Western blotting procedure was the same as that used previously
(20)
with the exception that 10% Tris-HCl BioRad
Ready Gels with 15 sample wells were used. Running conditions were 200
V for 35 min and electroblotting at 100 V for 60 min. Protein content
in sample wells was 17 µg and in positive control
wells (rat brain homogenate), 5 µg. Each sample was
analyzed in duplicate. Primary antibodies used were nPKC
(c-20),
nPKCßII(c-18) and nPKC
(c-20); the secondary
antibody was anti-rabbit immunoglobulin-AP (Santa Cruz
Biotechnology, Santa Cruz, CA). Blocking peptides of each PKC isoenzyme
(Santa Cruz Biotechnology) were used to ensure that the correct bands
from immunoblots were analyzed.
Vitamin C, carotenoids, tocopherols and total fatty acids were measured
from EDTA-plasma as markers of dietary compliance. For the ascorbic
acid assay, plasma (0.5 mL) was pipetted into 4.5 mL of 5%
metaphosphoric acid. The analysis was carried out with an automated
fluorimetric method (21)
. Plasma tocopherols and
carotenoids were analyzed separately by HPLC, tocopherols by
fluorescent detection (22)
and carotenoids by detection at
450 nm (23)
. Plasma total fatty acids were extracted and
analyzed by gas-liquid chromatography as described
(24)
.
For the analysis of biomarkers of oxidative status, plasma aliquots
were frozen immediately (-40°C) or delivered fresh to the Department
of Biochemistry, National Public Health Institute where LDL were
isolated by ultrasentrifugation at 260,000 x g for
3 h at 4°C (vertical rotor VT 65, 1 in a Beckman L-70
ultracentrifuge) after adjusting the density of plasma to 1.21 kg/L
with potassium bromide. The LDL-fraction was desalted (PD-10,
Sephadex, Pharmacia) and eluted with PBS. The test tubes were filled
with nitrogen and stored at 4°C overnight. The lag-time
of Cu2+-induced LDL oxidation in vitro was
analyzed as described (25)
. Malondialdehyde (MDA) was
measured as thiobarbituric acid-reactive substances
(26)
.
Statistical analysis of the data was performed with the Systat 5.2
program (Systat, Evanston, IL). Normality of the data was tested by
Lilliefors test. Depending on the normality of the data, parametric or
nonparametric tests were used. Possible differences between the
preexperimental period (PRE) levels in the different groups were
analyzed by ANOVA and the post-hoc Tukeys test. Differences from
PRE to the experimental period (EXP) within the treatment groups were
analyzed with paired t test or the Wilcoxon Signed Ranks
test. Difference between the treatment effects (
EXP-PRE within
treatment groups) was analyzed with independent samples t
test or the Mann-Whitney U test. Correlation analyses were
performed using Pearsons correlation or the Spearman rank-order
correlation. Statistical significance of difference was assumed at
P < 0.05.
| RESULTS |
|---|
|
|
|---|
-tocopherol concentrations (Table 3)
|
|
, ßII and
(Table 4)
Biomarkers of oxidative status, LDL-oxidation in vitro
and plasma MDA, did not differ between groups (Table 4)
. These
oxidative markers, plasma fatty acids, antioxidants, flavonoids and
lipoprotein fractions did not correlate with platelet PKC activity or
the distribution of isoenzymes (data not shown).
When data from all groups were combined, correlations between PKC total
activity and PKC cytosolic isoenzymes
(r = 0.47,
P = 0.003), ßII (r
= 0.44, P = 0.004) and
(r = 0.50, P = 0.001) were found at the end of the
experiment. Correlations between PKC activity and PKC membrane
isoenzymes
(r = 0.45, P = 0.004),
ßII (r = 0.50, P
= 0.001) and
(r = 0.35, P = 0.032) followed the same pattern. No correlations were found before the
experiment when the subjects consumed their habitual diets.
| DISCUSSION |
|---|
|
|
|---|
-tocopherol. In addition to the biomarkers shown
here, the plasma flavonoid quercetin, as well as the excretion of
several flavonoids in urine, were greater in the OA(+) group compared
with the LA(-) group (data not shown). Although the fatty acid and
antioxidant status changed differently in the experimental groups, no
differences between the groups were seen in platelet aggregation, PKC
activity or isoenzyme localization. Our results are consistent with one
earlier study in humans in which dietary linoleic acid and oleic acid
diets did not differently affect PKC activity (8)
The possibility of harmful fatty acid oxidation is suggested to
increase as the unsaturation of the fatty acids increases. Because PUFA
may be potential sources of oxidative stress in the body, a large
difference in PUFA intake was used in this study in an attempt to
change the oxidative status of the study groups. Another strategy to
modify the oxidative status was the use of vegetables, berries and
apples, which contain antioxidants and other bioactive molecules that
may prevent oxidative stress. The intake of PUFA in the LA(-) group
was very close to the maximal possible intake from a normal mixed diet,
whereas the intake of vegetable compounds was kept very low. In the
OA(+) group, intake of PUFA was considerably lower and the main dietary
fatty acids were MUFA. The portions of vegetables, berries and unpeeled
apples in the OA(+) group were approximately fourfold higher than in
the normal Finnish diet (27)
. It is almost impossible to
increase amounts of vegetables, fruits and berries (and thus the
possible bioactive plant molecules) from normal mixed dietary sources
more than was done in this study without supplementation because
portions would be too large to consume. In supplementation trials, it
is possible to use pharmacologic doses but their relevance to normal
physiology is questionable. Lipid peroxidation or LDL oxidation did not
change differently in the present study, indicating that the LA(-)
diet did not increase or the OA(+) diet decrease oxidative stress in
our healthy subjects.
Oxidative compounds may cause platelet hyperactivation and this can be
seen as a risk factor for thrombosis. Unwanted platelet activation
could proceed through PKC enzyme activation. Cis-unsaturated
fatty acids and oxidation products of unsaturated fatty acids can
activate PKC in vitro (7
,12)
and also induce PKC
translocation to the plasma membrane (9
,10)
. These
mechanisms seemed not to be involved here, i.e., the changes found in
the experimental groups in platelet aggregation or PKC did not differ
from those found in the control group.
Plasma concentrations of vitamin C, carotenoids and quercetin were
higher in the OA(+) group, whereas
-tocopherol was higher in the
LA(-) group. In vitro studies have shown that these and other
bioactive molecules from vegetables, berries and apples inhibit
platelet activation, and this may be mediated at least in part by PKC
inhibition (18
,28)
. In this study,
-tocopherol or
vegetable compounds did not inhibit platelet aggregation or PKC
compared with the controls. Studies that have found
-tocopherol to
inhibit PKC activity have used pharmacologic doses of supplementation,
thus comparisons with our results are questionable (14)
.
Because fatty acids activate platelet PKC in vitro, we wanted to
determine whether there were correlations between fatty acids and PKC.
Plasma total fatty acid composition was measured in this study, but not
platelet fatty acid composition. No correlations between plasma total
fatty acids and platelet PKC total activity or isoenzymes were found.
One reason may be that because only certain phospholipid classes seem
to be involved in PKC activation (29)
, plasma total fatty
acids may be far too crude a marker to reflect associations between
platelet phospholipid fatty acid composition and PKC activation.
It is difficult to explain why PKC activity and all three isoenzymes
studied correlated at the end of the experiment but not at the
beginning. It is possible that the experimental diets had some effect
on platelet PKC, after all. The dietary changes may have favored
participation of PKC isoenzymes
, ßII and
in PKC activity compared with consumption of habitual diets.
The use of PKC in dietary interventions has been quite rare. Our study indicates that there might be some difficulties using PKC in in vivo interventions. Because intraindividual variation in PKC activity and isoenzyme localization seems to be quite large, the study populations should be much larger than that used here to be able to detect small changes in these variables. This study also showed the importance of the control group in dietary interventions, i.e., a small time trend in PKC activity and isoenzyme translocation could have led to incorrect conclusions without the control group.
Earlier studies have shown that even a 4-wk period is long enough
to induce differences in fatty acid profiles and physiologic responses
during different dietary treatments (8
,19)
. In this study,
6 wk was enough to induce changes in dietary compliance markers.
Nevertheless, in our apparently healthy and fairly young subjects with
adequate vitamin intakes, modification of dietary unsaturated fatty
acids and vegetable compounds did not change the balance in the body,
and platelet activation remained unchanged, as monitored by platelet
aggregation and a specific enzyme of platelet activation, PKC.
| FOOTNOTES |
|---|
, ßII,
translocation in healthy subjects).
2 Supported by the Academy of Finland (project number 101 41399), the Ministry of Agriculture and Forestry, the University of Helsinki. ![]()
4 Abbreviations used: CVD, cardiovascular diseases; EXP, experimental period; LA(-), diet rich in PUFA (mainly linoleic acid) and low in vegetables, no berries or apples; MDA, malondialdehyde; MUFA, monounsaturated fatty acids; en%, percentage of daily energy intake; OA(+), diet rich in MUFA (mainly oleic acid) and high in vegetables, berries and apples; PKC, protein kinase C; PRE, preexperimental period; PUFA, polyunsaturated fatty acids. ![]()
Manuscript received September 5, 2000. Initial review completed November 1, 2000. Revision accepted March 2, 2001.
| REFERENCES |
|---|
|
|
|---|
1. Farstad M. The role of blood platelets in coronary atherosclerosis and thrombosis. Scand. J. Clin. Lab. Investig. 1998;58:1-10[Medline]
2. Wu K. K. Platelet activation mechanisms and markers in arterial thrombosis. J. Intern. Med. 1996;239:17-34[Medline]
3.
Knapp H. Dietary fatty acids in human thrombosis and hemostasis. Am. J. Clin Nutr. 1997;65(suppl.):1687S-1698S
4.
Hannun Y. A., Greenberg C. S., Bell R. M. Sphingosine inhibition of agonist-dependent secretion and activation of human platelets implies that protein kinase C is a necessary and common event of the signal transduction pathways. J. Biol. Chem. 1987;262:13620-13626
5.
Barry O. P., Kazanietz M. G., Praticó D., FitzGerald G. A. Arachidonic acid in platelet microparticles up-regulates cyclooxygenase-2-dependent prostaglandin formation via a protein kinase C/mitogen-activated protein kinase-dependent pathway. J. Biol. Chem. 1999;274:7545-7556
6. Nishizuka Y. The role of protein kinase C in cell surface signal transduction and tumour promotion. Nature (Lond.) 1984;308:693-698[Medline]
7. Nishikawa M., Hidaka H., Shirakawa S. Possible involvement of direct stimulation of protein kinase C by unsaturated fatty acids in platelet activation. Biochem. Pharmacol. 1988;37:3079-3089[Medline]
8. Turpeinen A. M., Pajari A. M., Freese R., Sauer R., Mutanen M. Replacement of dietary saturated by unsaturated fatty acids: effects of platelet protein kinase C activity, urinary content of 2,3-dinor-TXB2 and in vitro platelet aggregation in healthy man. Thromb. Haemostasis 1998;80:649-655[Medline]
9.
Khan W. A., Blobe G., Halpern A., Taylor W., Wetsel W. C., Burns D., Loomis C., Hannun Y. A. Selective regulation of protein kinase C isoenzymes by oleic acid in human platelets. J. Biol. Chem. 1993;268:5063-5068
10. Huang Z. H., Hii C.S.T., Rathjen D. A., Poulos A., Murray A. W., Ferrante A. N-6 and n-3 polyunsaturated fatty acids stimulate translocation of protein kinase C-alpha, -betaI, -betaII and -epsilon and agonist-induced NADPH oxidase in macrophages. Biochem. J. 1997;325:553-557
11.
Praticó D., Pasin M., Barry O. P., Ghiselli A., Sabatino G., Iuliano L., FitzGerald G. A., Violi F. Iron-dependent human platelet activation and hydroxyl radical formation: involvement of protein kinase C. Circulation 1999;99:3118-3124
12. OBrian C. A., Ward N. E., Weinstein I. B., Bull A. W., Marnett L. J. Activation of rat brain protein kinase C by lipid oxidation products. Biochem. Biophys. Res. Commun. 1988;155:1374-1380[Medline]
13.
Ohmori S., Shirai Y., Sakai N., Fujii M., Konishi H., Kikkawa U., Saito N. Three distinct mechanisms for translocation and activation of the delta subspecies of protein kinase C. Mol. Cell. Biol. 1998;18:5263-5271
14.
Freedman J. E., Farhat J. H., Loscalzo J., Keaney J. F.
-Tocopherol inhibits aggregation of human platelets by a protein kinase C-dependent mechanism. Circulation 1996;94:2434-2440
15.
Tasinato A., Boscoboinic D., Bartoli G. M., Maroni P., Azzi A. d-
-Tocopherol inhibition of vascular smooth muscle cell proliferation occurs at physiological concentrations, correlates with protein kinase C inhibition, and is independent of its antioxidant properties. Proc. Natl. Acad. Sci. U.S.A. 1995;92:12190-12194
16.
Rizziarelli R., Tasinato A., Clément S., Özer N. K., Boscoboinik D., Azzi A.
-Tocopherol specifically inactivates cellular protein kinase C alpha by changing its phosphorylation state. Biochem. J. 1998;334:243-249
17.
Steiner M., Li W., Ciaramella J. M., Anagnostou A., Sigounas G. dl-
-Tocopherol, a potent inhibitor of phorbol ester induced shape change of erythro- and megakaryoblastic leukaemia cells. J. Cell. Physiol. 1997;172:351-360[Medline]
18. Agullo G., Gamet-Payrastre L., Manenti S., Viala C., Rémésy C., Chap H., Payrastre B. Relationship between flavonoid structure and inhibition of phosphatidylinositol 3-kinase: a comparison with tyrosine and protein kinase C inhibition. Biochem. Pharmacol. 1997;53:1649-1657[Medline]
19. Mutanen M., Freese R., Valsta L. M., Ahola I., Ahlström A. Rapeseed oil and sunflower oil diets enhance platelet in vitro aggregation and thromboxane production in healthy men when compared with milk fat or habitual diets. Thromb. Haemostasis 1992;67:352-356[Medline]
20. Pajari A. M., Oikarinen S., Gråsten S., Mutanen M. Diets enriched with cereal brans or inulin modulate protein kinase C activity and isoenzyme expression in rat colonic mucosa. Br. J. Nutr. 2000;84:635-643[Medline]
21. Brubacher G., Vuilleumier J. P. Vitamin C. Curtius H. C. Roth M. eds. Clinical Biochemistry. Principles and Methods 2nd ed. 1974:989-997 Walter de Gruyter Berlin, Germany
22. Anttolainen M., Valsta L., Alfthan G., Kleemola P., Salminen I., Tamminen M. Effect of extreme fish consumption on dietary and plasma antioxidant levels and fatty acid composition. Eur. J. Clin. Nutr. 1996;50:741-746[Medline]
23. Bieri J. G., Brown E. D., Smith J. C. Determination of individual carotenoids in human plasma by high performance liquid chromatography. J. Liquid Chromatogr. 1985;8:473-484
24. Salminen I., Mutanen M., Jauhiainen M., Aro A. Dietary trans fatty acids increase conjugated linoleic acid levels in human serum. J. Nutr. Biochem. 1998;9:93-98
25. Esterbauer H., Striegl H., Puhl H. Continuous monitoring of in vitro oxidation of human low density lipoprotein. Free Radic. Res. Commun. 1989;6:67-75[Medline]
26. Wade C. R., van Rij A. M. Plasma thiobarbituric acid reactivity: reaction conditions and the role of iron, antioxidants and lipid peroxy radicals on the quantitation of plasma lipid peroxides. Life Sci 1988;43:1085-1093[Medline]
27. The National Public Health Institute The 1997 Dietary Survey of Finnish adults 1998 Publications of the National Public Health Institute B8/1998 Helsinki, Finland.
28.
Pignatelli P., Pulcinelli F. M., Celestini A., Lenti L., Ghiselli A., Gazzaniga P. P., Violi F. The flavonoids quercetin and catechin synergistically inhibit platelet function by antagonizing the intracellular production of hydrogen peroxide. Am. J. Clin. Nutr. 2000;72:1150-1155
29. Pajari A. M., Mutanen M. Phospholipid fatty acid composition and protein kinase C activity in the large intestine of rats fed on butter and coconut-oil diets. Br. J. Nutr. 1999;82:411-418[Medline]
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||